An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy

Abstract Background A significant proportion of cardiomyopathy patients remain genetically unsolved. Our aim was to use the large genomes cohort of the 100,000 genomes project (100KGP) to explore the proportion of potentially causal mitochondrial (mtDNA) variants in cardiomyopathy patients, particul...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis R. Lopes, William L. Macken, Seth Du Preez, Huafrin Kotwal, Konstantinos Savvatis, Neha Sekhri, Saidi A. Mohiddin, Renata Kabiljo, Robert D. S. Pitceathly
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Human Genomics
Subjects:
Online Access:https://doi.org/10.1186/s40246-024-00702-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849220637053157376
author Luis R. Lopes
William L. Macken
Seth Du Preez
Huafrin Kotwal
Konstantinos Savvatis
Neha Sekhri
Saidi A. Mohiddin
Renata Kabiljo
Robert D. S. Pitceathly
author_facet Luis R. Lopes
William L. Macken
Seth Du Preez
Huafrin Kotwal
Konstantinos Savvatis
Neha Sekhri
Saidi A. Mohiddin
Renata Kabiljo
Robert D. S. Pitceathly
author_sort Luis R. Lopes
collection DOAJ
description Abstract Background A significant proportion of cardiomyopathy patients remain genetically unsolved. Our aim was to use the large genomes cohort of the 100,000 genomes project (100KGP) to explore the proportion of potentially causal mitochondrial (mtDNA) variants in cardiomyopathy patients, particularly in genotype-elusive participants. The homoplasmic MT-TI 4300A>G is unusual in that it typically presents with a cardiac-only phenotype, but MT-TI is currently not part of the genes analysed for non-syndromic cardiomyopathies. Results We analysed 1363 cardiomyopathy genomes from the 100KGP project (of which only 172 had been previously solved) to detect disease causing mtDNA variants. MitoHPC was used to call variants. For controls, 1329 random subjects not recruited for a cardiomyopathy diagnosis and not related to any participant in the cardiomyopathy cohort were selected. We have additionally compared the frequency of detected variants with published UK Biobank data. Pathogenicity annotations were assigned based on MitoMap. Four patients, all with a diagnosis of hypertrophic cardiomyopathy (HCM) and without a previously identified genetic cause from the 100KGP clinical-standard analysis, were found to harbour the pathogenic MT-TI m.4300A>G variant (0.6% of HCM cases without a diagnosis). Conclusion These data support the inclusion of MT-TI in the initial genetic testing panel for (non-syndromic) HCM.
format Article
id doaj-art-2b61615b836e47ab8a0aa206e4bab0d6
institution Kabale University
issn 1479-7364
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Human Genomics
spelling doaj-art-2b61615b836e47ab8a0aa206e4bab0d62024-12-08T12:37:30ZengBMCHuman Genomics1479-73642024-12-011811410.1186/s40246-024-00702-9An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathyLuis R. Lopes0William L. Macken1Seth Du Preez2Huafrin Kotwal3Konstantinos Savvatis4Neha Sekhri5Saidi A. Mohiddin6Renata Kabiljo7Robert D. S. Pitceathly8Institute of Cardiovascular Science, University College LondonDepartment of Neuromuscular Diseases, University College London Queen Square Institute of NeurologyNHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and NeurosurgerySt. Bartholomew’s Hospital, Barts Heart CentreInstitute of Cardiovascular Science, University College LondonSt. Bartholomew’s Hospital, Barts Heart CentreSt. Bartholomew’s Hospital, Barts Heart CentreDepartment of Neuromuscular Diseases, University College London Queen Square Institute of NeurologyDepartment of Neuromuscular Diseases, University College London Queen Square Institute of NeurologyAbstract Background A significant proportion of cardiomyopathy patients remain genetically unsolved. Our aim was to use the large genomes cohort of the 100,000 genomes project (100KGP) to explore the proportion of potentially causal mitochondrial (mtDNA) variants in cardiomyopathy patients, particularly in genotype-elusive participants. The homoplasmic MT-TI 4300A>G is unusual in that it typically presents with a cardiac-only phenotype, but MT-TI is currently not part of the genes analysed for non-syndromic cardiomyopathies. Results We analysed 1363 cardiomyopathy genomes from the 100KGP project (of which only 172 had been previously solved) to detect disease causing mtDNA variants. MitoHPC was used to call variants. For controls, 1329 random subjects not recruited for a cardiomyopathy diagnosis and not related to any participant in the cardiomyopathy cohort were selected. We have additionally compared the frequency of detected variants with published UK Biobank data. Pathogenicity annotations were assigned based on MitoMap. Four patients, all with a diagnosis of hypertrophic cardiomyopathy (HCM) and without a previously identified genetic cause from the 100KGP clinical-standard analysis, were found to harbour the pathogenic MT-TI m.4300A>G variant (0.6% of HCM cases without a diagnosis). Conclusion These data support the inclusion of MT-TI in the initial genetic testing panel for (non-syndromic) HCM.https://doi.org/10.1186/s40246-024-00702-9Mitochondrial DNAm.4300A>GHypertrophic cardiomyopathyWhole Genome Sequencing
spellingShingle Luis R. Lopes
William L. Macken
Seth Du Preez
Huafrin Kotwal
Konstantinos Savvatis
Neha Sekhri
Saidi A. Mohiddin
Renata Kabiljo
Robert D. S. Pitceathly
An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy
Human Genomics
Mitochondrial DNA
m.4300A>G
Hypertrophic cardiomyopathy
Whole Genome Sequencing
title An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy
title_full An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy
title_fullStr An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy
title_full_unstemmed An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy
title_short An analysis of mitochondrial variation in cardiomyopathy patients from the 100,000 genomes cohort: m.4300A>G as a cause of genetically elusive hypertrophic cardiomyopathy
title_sort analysis of mitochondrial variation in cardiomyopathy patients from the 100 000 genomes cohort m 4300a g as a cause of genetically elusive hypertrophic cardiomyopathy
topic Mitochondrial DNA
m.4300A>G
Hypertrophic cardiomyopathy
Whole Genome Sequencing
url https://doi.org/10.1186/s40246-024-00702-9
work_keys_str_mv AT luisrlopes ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT williamlmacken ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT sethdupreez ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT huafrinkotwal ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT konstantinossavvatis ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT nehasekhri ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT saidiamohiddin ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT renatakabiljo ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT robertdspitceathly ananalysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT luisrlopes analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT williamlmacken analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT sethdupreez analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT huafrinkotwal analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT konstantinossavvatis analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT nehasekhri analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT saidiamohiddin analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT renatakabiljo analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy
AT robertdspitceathly analysisofmitochondrialvariationincardiomyopathypatientsfromthe100000genomescohortm4300agasacauseofgeneticallyelusivehypertrophiccardiomyopathy